Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. <i>Viruses</i> 2021, <i>13</i>, 1199”
We would like to thank Stroobandt, S. and Stroobandt, R. for showing interest in our paper [...]
| Published in: | Viruses |
|---|---|
| Main Authors: | Sarah Stuckelberger, Guillaume Favre, Michael Ceulemans, Eva Gerbier, Valentine Lambelet, Milos Stojanov, Ursula Winterfeld, David Baud, Alice Panchaud, Léo Pomar |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-08-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/13/8/1546 |
Similar Items
Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
by: Qi Ma, et al.
Published: (2025-01-01)
by: Qi Ma, et al.
Published: (2025-01-01)
mRNA-Based Vaccines
by: Frank Kowalzik, et al.
Published: (2021-04-01)
by: Frank Kowalzik, et al.
Published: (2021-04-01)
Excipients and mRNA vaccines
by: Shireesh Apte
Published: (2020-12-01)
by: Shireesh Apte
Published: (2020-12-01)
The History of mRNA Vaccine
by: Maham Akhlaq
Published: (2021-06-01)
by: Maham Akhlaq
Published: (2021-06-01)
Dangers of mRNA vaccines
by: Tahoora Ali, et al.
Published: (2021-01-01)
by: Tahoora Ali, et al.
Published: (2021-01-01)
Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
by: Suresh Babu Chellapandian, et al.
Published: (2022-04-01)
by: Suresh Babu Chellapandian, et al.
Published: (2022-04-01)
mRNA vaccines as cancer therapies
by: Shaoxiong Huang, et al.
Published: (2024-12-01)
by: Shaoxiong Huang, et al.
Published: (2024-12-01)
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)
by: Zixin Fang, et al.
Published: (2024-12-01)
mRNA Innovates the Vaccine Field
by: Norbert Pardi
Published: (2021-05-01)
by: Norbert Pardi
Published: (2021-05-01)
The advances of adjuvants in mRNA vaccines
by: Chunyuan Xie, et al.
Published: (2023-10-01)
by: Chunyuan Xie, et al.
Published: (2023-10-01)
mRNA Vaccines against Flaviviruses
by: Clayton J. Wollner, et al.
Published: (2021-02-01)
by: Clayton J. Wollner, et al.
Published: (2021-02-01)
Recent Updates on mRNA Vaccines
by: Emily Sydow, et al.
Published: (2022-07-01)
by: Emily Sydow, et al.
Published: (2022-07-01)
Neo-Antigen mRNA Vaccines
by: Arthur Esprit, et al.
Published: (2020-12-01)
by: Arthur Esprit, et al.
Published: (2020-12-01)
The Delivery of mRNA Vaccines for Therapeutics
by: Nitika, et al.
Published: (2022-08-01)
by: Nitika, et al.
Published: (2022-08-01)
mRNA vaccine for cancer immunotherapy
by: Lei Miao, et al.
Published: (2021-02-01)
by: Lei Miao, et al.
Published: (2021-02-01)
Progress and challenges of mRNA vaccines
by: Liangru Lin, et al.
Published: (2023-01-01)
by: Liangru Lin, et al.
Published: (2023-01-01)
iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA
by: Sean Yanik, et al.
Published: (2025-02-01)
by: Sean Yanik, et al.
Published: (2025-02-01)
COVID-19 mRNA vaccination during pregnancy does not harm syncytiotrophoblast development
by: Jantine van Voorden, et al.
Published: (2024-03-01)
by: Jantine van Voorden, et al.
Published: (2024-03-01)
Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. <i>Viruses</i> 2021, <i>13</i>, 1199
by: Serge Stroobandt, et al.
Published: (2021-08-01)
by: Serge Stroobandt, et al.
Published: (2021-08-01)
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
by: Oleguer Parés-Badell, et al.
Published: (2022-07-01)
by: Oleguer Parés-Badell, et al.
Published: (2022-07-01)
Have mRNA vaccines sentenced DNA vaccines to death?
by: Alberto Cagigi, et al.
Published: (2023-12-01)
by: Alberto Cagigi, et al.
Published: (2023-12-01)
mRNA vaccines: Past, present, future
by: Mia Karam, et al.
Published: (2022-07-01)
by: Mia Karam, et al.
Published: (2022-07-01)
Commentary of the mRNA vaccines COVID-19
by: Antonio Vitiello, et al.
Published: (2021-09-01)
by: Antonio Vitiello, et al.
Published: (2021-09-01)
pDNA Impurities in mRNA Vaccines
by: Luca Roncati, et al.
Published: (2025-08-01)
by: Luca Roncati, et al.
Published: (2025-08-01)
Antitumor mRNA vaccines based on neoantigens
by: E. V. Starostina, et al.
Published: (2025-01-01)
by: E. V. Starostina, et al.
Published: (2025-01-01)
Recent progress in mRNA cancer vaccines
by: Ruhui Yao, et al.
Published: (2024-12-01)
by: Ruhui Yao, et al.
Published: (2024-12-01)
Combinative workflow for mRNA vaccine development
by: Renuka Khanzode, et al.
Published: (2024-09-01)
by: Renuka Khanzode, et al.
Published: (2024-09-01)
The global mRNA vaccine patent landscape
by: Mengyao Li, et al.
Published: (2022-11-01)
by: Mengyao Li, et al.
Published: (2022-11-01)
An Update on mRNA-Based Viral Vaccines
by: Subbiah Jeeva, et al.
Published: (2021-08-01)
by: Subbiah Jeeva, et al.
Published: (2021-08-01)
mRNA vaccines in disease prevention and treatment
by: Gang Zhang, et al.
Published: (2023-09-01)
by: Gang Zhang, et al.
Published: (2023-09-01)
Emergence of mRNA vaccines in the management of cancer
by: Mohamad Irfan Mohamad Razif, et al.
Published: (2023-12-01)
by: Mohamad Irfan Mohamad Razif, et al.
Published: (2023-12-01)
Advances in mRNA-Based Cancer Vaccines
by: Ling Ni
Published: (2023-10-01)
by: Ling Ni
Published: (2023-10-01)
Mechanism of action of mRNA-based vaccines
by: Carlo Iavarone, et al.
Published: (2017-09-01)
by: Carlo Iavarone, et al.
Published: (2017-09-01)
mRNA Vaccine Nanoplatforms and Innate Immunity
by: Lai Wei, et al.
Published: (2024-01-01)
by: Lai Wei, et al.
Published: (2024-01-01)
Research Advances on the Stability of mRNA Vaccines
by: Feiran Cheng, et al.
Published: (2023-03-01)
by: Feiran Cheng, et al.
Published: (2023-03-01)
Nanomaterial Delivery Systems for mRNA Vaccines
by: Michael D. Buschmann, et al.
Published: (2021-01-01)
by: Michael D. Buschmann, et al.
Published: (2021-01-01)
COVID-19 mRNA Vaccine and Myocarditis
by: Balraj Singh, et al.
Published: (2021-06-01)
by: Balraj Singh, et al.
Published: (2021-06-01)
mRNA vaccines in the prevention and treatment of diseases
by: Yangzhuo Gu, et al.
Published: (2022-09-01)
by: Yangzhuo Gu, et al.
Published: (2022-09-01)
Development and Delivery Systems of mRNA Vaccines
by: Yongjun Liang, et al.
Published: (2021-07-01)
by: Yongjun Liang, et al.
Published: (2021-07-01)
mRNA therapeutics: New vaccination and beyond
by: Huan-Huan Wei, et al.
Published: (2023-09-01)
by: Huan-Huan Wei, et al.
Published: (2023-09-01)
Similar Items
-
Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
by: Qi Ma, et al.
Published: (2025-01-01) -
mRNA-Based Vaccines
by: Frank Kowalzik, et al.
Published: (2021-04-01) -
Excipients and mRNA vaccines
by: Shireesh Apte
Published: (2020-12-01) -
The History of mRNA Vaccine
by: Maham Akhlaq
Published: (2021-06-01) -
Dangers of mRNA vaccines
by: Tahoora Ali, et al.
Published: (2021-01-01)
